â– LECTURE OVERVIEW: Kawasaki Disease is an acute, self-limiting medium-vessel necrotizing vasculitis that primarily affects infants and toddlers.
â– SPECIFIC TOXIC CHANNELS:
1. Endothelial Inflammation: Characterized by segment-like inflammation of muscular medium arteries, particularly coronary arteries.
2. Clinical Diagnoses: Requires high fever lasting over 5 days, plus at least 4 of 5 CRASH symptoms:
- C - Conjunctivitis (bilateral, non-purulent, sparing the limbus).
- R - Rash (polymorphous, erythematous).
- A - Adenopathy (cervical, unilateral, node >1.5 cm).
- S - Strawberry tongue (erythematous, with cracked red lips).
- H - Hand/foot swelling initially, with desquamation of skin under nails in recovery.
â– BIOCHEMICAL MECHANISMS:
At the molecular level, enzyme kinetics govern reaction rates. Competitive inhibitors raise apparent Michaelis constants without changing maximum speed, whereas noncompetitive inhibitors decrease maximum speed directly.
â– PROFESSOR'S CRITICAL SYNTHESIS:
Understanding the transition point from reversible cell injury to irreversible cellular death is the most fundamental concept in clinical medicine.
[HY-BOARD-1310]
🌟 Dynamic Clinical Key:
Carries a high risk of developing coronary artery aneurysms in up to 25% of untreated cases. Crucially, Kawasaki disease is the only clinical condition where Aspirin (which is otherwise contraindicated in children due to Reye's syndrome) is administered, alongside intravenous immunoglobulin (IVIG). Focus on rate-limiting regulatory steps for pharmacological design. Connect microscopic cellular structure with patient presentation to develop a unified diagnostic vision.